Summary
Merck & Co., Inc. (MRK) filed an 8-K on February 3, 2016, to report its financial results for the fourth quarter and full year of 2015. The report primarily incorporates by reference a press release (Exhibit 99.1) and supplemental financial information (Exhibit 99.2), which contain the detailed operational and financial performance for the specified periods. Investors should refer to these attached exhibits for specific figures related to revenue, earnings, and other key financial metrics that would inform an assessment of the company's performance and financial health at that time.
Key Highlights
- 1The 8-K filing primarily serves to disclose Merck's fourth quarter and full year 2015 financial results.
- 2Detailed financial performance is provided through an incorporated press release (Exhibit 99.1).
- 3Supplemental financial information not included in the press release is also attached as Exhibit 99.2.
- 4The filing was made on February 3, 2016, reflecting events that occurred on or around February 2, 2016.
- 5This report is crucial for investors to understand Merck's financial standing and operational outcomes for the 2015 fiscal year.
- 6The information provided is for the period ending December 31, 2015.
- 7The filing does not contain new material events beyond the earnings release itself.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially report Merck & Co., Inc.'s financial results for the fourth quarter and the full fiscal year of 2015.
The actual financial results are not detailed directly in the 8-K itself. Instead, they are incorporated by reference through two exhibits: Exhibit 99.1, which is a press release detailing the fourth quarter and full year 2015 earnings, and Exhibit 99.2, which provides additional supplemental financial information.
No, this 8-K filing is specifically focused on reporting historical financial performance for the fourth quarter and full year 2015. It does not disclose any new material business events, acquisitions, divestitures, or significant strategic shifts beyond the financial results themselves.
The disclaimer indicates that the information furnished in this Item 2.02, specifically the press release and supplemental information, is not considered legally 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This generally means the company may have less liability under that specific section for the contents, though it's still material information for investors.